Study of family physicians' practices in case of urinary tract infections caused by enterobacteriaceae secreting extended-spectrum-beta-lactamase
Urinary tract infections caused by enterobacteriaceae secreting extended-spectrum beta-lactamase (EESBL) is an issue for most family physicians. The aim of our study was to evaluate their practice in case of EESBL discovered after urinalysis and culture (U/C). This epidemiological and retrospective study was conducted from the January 1, to December 31, 2012, in 5 laboratories of Savoie and Isere. Results of U/C prescribed by family physicians and positive for EESBL were collected. The data collected with questionnaires, concerned characteristics of the infection, antibiotic treatment adequateness, the implementation of specific hygiene measures, and risk factors for EESBL infection. One hundred and three U/C out of 19,494 were considered, and 56 questionnaires were collected. The rate of EESBL positive U/C was 0.60%. The antibiotic treatment was adequate for 35 patients (62.5%). Specific hygiene measures were implemented for 22 patients (32.3%). Both antibiotic treatment and specific hygiene measures were initiated for 13 patients (23.2%). Fourteen cases of community-acquired infections (25%) were reported. Five patients (8.9%) had traveled to an endemic zone in the previous 6 months. The concomitant initiation of both antibiotic treatment and specific hygiene measures in case of U/C positive for EESBL is insufficient when managed by family physicians. It could be improved by offering tools for the management of these infections, by developing EESBL networks between hospital and family physicians, and epidemiological surveillance in community settings..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
|---|---|
| Enthalten in: |
Médecine et maladies infectieuses - 45(2015), 3, Seite 78-83 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Miclot, C [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.1016/j.medmal.2015.01.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC196742411X |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC196742411X | ||
| 003 | DE-627 | ||
| 005 | 20211208190249.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.medmal.2015.01.004 |2 doi | |
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC196742411X | ||
| 035 | |a (DE-599)GBVOLC196742411X | ||
| 035 | |a (PRQ)c1283-55f80c350d4a6ce45a14061d429e3695c32df19b1ab1c4901ac2eb760780cd800 | ||
| 035 | |a (KEY)0073612020150000045000300078studyoffamilyphysicianspracticesincaseofurinarytra | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |q ZDB |
| 100 | 1 | |a Miclot, C |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Study of family physicians' practices in case of urinary tract infections caused by enterobacteriaceae secreting extended-spectrum-beta-lactamase |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Urinary tract infections caused by enterobacteriaceae secreting extended-spectrum beta-lactamase (EESBL) is an issue for most family physicians. The aim of our study was to evaluate their practice in case of EESBL discovered after urinalysis and culture (U/C). This epidemiological and retrospective study was conducted from the January 1, to December 31, 2012, in 5 laboratories of Savoie and Isere. Results of U/C prescribed by family physicians and positive for EESBL were collected. The data collected with questionnaires, concerned characteristics of the infection, antibiotic treatment adequateness, the implementation of specific hygiene measures, and risk factors for EESBL infection. One hundred and three U/C out of 19,494 were considered, and 56 questionnaires were collected. The rate of EESBL positive U/C was 0.60%. The antibiotic treatment was adequate for 35 patients (62.5%). Specific hygiene measures were implemented for 22 patients (32.3%). Both antibiotic treatment and specific hygiene measures were initiated for 13 patients (23.2%). Fourteen cases of community-acquired infections (25%) were reported. Five patients (8.9%) had traveled to an endemic zone in the previous 6 months. The concomitant initiation of both antibiotic treatment and specific hygiene measures in case of U/C positive for EESBL is insufficient when managed by family physicians. It could be improved by offering tools for the management of these infections, by developing EESBL networks between hospital and family physicians, and epidemiological surveillance in community settings. | ||
| 540 | |a Nutzungsrecht: Copyright © 2015 Elsevier Masson SAS. All rights reserved. | ||
| 650 | 4 | |a Enterobacteriaceae Infections - prevention & control | |
| 650 | 4 | |a Enterobacteriaceae - enzymology | |
| 650 | 4 | |a Enterobacteriaceae Infections - microbiology | |
| 650 | 4 | |a Enterobacteriaceae - drug effects | |
| 650 | 4 | |a Anti-Bacterial Agents - classification | |
| 650 | 4 | |a Enterobacteriaceae Infections - drug therapy | |
| 650 | 4 | |a Urinary Tract Infections - microbiology | |
| 650 | 4 | |a Enterobacteriaceae - genetics | |
| 650 | 4 | |a Drug Resistance, Multiple, Bacterial - genetics | |
| 650 | 4 | |a Urinary Tract Infections - prevention & control | |
| 650 | 4 | |a Practice Patterns, Physicians' - statistics & numerical data | |
| 650 | 4 | |a Urinary Tract Infections - epidemiology | |
| 650 | 4 | |a Urinary Tract Infections - drug therapy | |
| 650 | 4 | |a Enterobacteriaceae Infections - epidemiology | |
| 650 | 4 | |a beta-Lactamases - analysis | |
| 650 | 4 | |a Anti-Bacterial Agents - therapeutic use | |
| 650 | 4 | |a Anti-Bacterial Agents - pharmacology | |
| 650 | 4 | |a Physicians, Family - statistics & numerical data | |
| 650 | 4 | |a Bacterial Proteins - analysis | |
| 650 | 4 | |a beta-Lactam Resistance - genetics | |
| 700 | 1 | |a Antoniotti, G |4 oth | |
| 700 | 1 | |a Forestier, E |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Médecine et maladies infectieuses |d Amsterdam [u.a.] : Elsevier Masson, 1971 |g 45(2015), 3, Seite 78-83 |w (DE-627)167176048 |w (DE-600)423536-8 |w (DE-576)9167176046 |x 0399-077X |7 nnns |
| 773 | 1 | 8 | |g volume:45 |g year:2015 |g number:3 |g pages:78-83 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.medmal.2015.01.004 |3 Volltext |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/25676475 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 45 |j 2015 |e 3 |h 78-83 | ||